We came across a bullish thesis on Compass Therapeutics, Inc. on r/stocks by Cute_Confidence6033. In this article, we will summarize the bulls’ thesis on CMPX. Compass Therapeutics, Inc.'s share was trading at $5.70 as of January 16th.
Compass Therapeutics (CMPX) is a clinical-stage oncology company with a focused pipeline targeting large, underserved cancer markets, and its current valuation appears disconnected from the scale of its opportunity. With a share price around $6 and a market capitalization of approximately $1.2 billion, the company holds a strong cash...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.